rac-1-([1,1'-biphenyl]-4-yloxy)-3-(4-(pyridin-2-yl)piperazin-1-yl)propan-2-ol

ID: ALA4641529

PubChem CID: 2940158

Max Phase: Preclinical

Molecular Formula: C24H27N3O2

Molecular Weight: 389.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OC(COc1ccc(-c2ccccc2)cc1)CN1CCN(c2ccccn2)CC1

Standard InChI:  InChI=1S/C24H27N3O2/c28-22(18-26-14-16-27(17-15-26)24-8-4-5-13-25-24)19-29-23-11-9-21(10-12-23)20-6-2-1-3-7-20/h1-13,22,28H,14-19H2

Standard InChI Key:  LWUOYPKNHLJBKL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   37.9899   -2.9791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9886   -3.8065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7035   -4.2193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4199   -3.8060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4170   -2.9754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7017   -2.5664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7051   -5.0422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9889   -5.4539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9883   -6.2781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7033   -6.6916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4202   -6.2748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4172   -5.4519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6992   -1.7414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.4124   -1.3267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1281   -1.7371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1306   -2.5620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.8413   -1.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5570   -1.7328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.5595   -2.5578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2702   -1.3182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9860   -1.7285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9884   -2.5535    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.7041   -2.9639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2752   -2.9682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7034   -3.7885    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.4182   -4.1988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1324   -3.7842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1273   -2.9549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4119   -2.5484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
  6 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 19 24  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 23  1  0
M  END

Associated Targets(Human)

SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.50Molecular Weight (Monoisotopic): 389.2103AlogP: 3.31#Rotatable Bonds: 7
Polar Surface Area: 48.83Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.23CX LogP: 3.97CX LogD: 3.74
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -1.46

References

1. Chang Q, Long J, Hu L, Chen Z, Li Q, Hu G..  (2020)  Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.,  28  (9): [PMID:32216987] [10.1016/j.bmc.2020.115404]

Source